Healthcare provider profile · identity verified

Stanley S Ling, MD

Internal Medicine · EVERETT, WA · NPI 1457372294

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	397	63
Atorvastatin Calcium	Atorvastatin Calcium	363	73
Levothyroxine Sodium	Levothyroxine Sodium	302	47
Amlodipine Besylate	Amlodipine Besylate	258	44
Eliquis	Apixaban	257	37
Furosemide	Furosemide	209	42
Lisinopril	Lisinopril	203	40
Losartan Potassium	Losartan Potassium	171	35
Tamsulosin Hcl	Tamsulosin Hcl	151	31
Metoprolol Tartrate	Metoprolol Tartrate	144	29
Potassium Chloride	Potassium Chloride	136	23
Metoprolol Succinate	Metoprolol Succinate	126	28
Sertraline Hcl	Sertraline Hcl	125	18
Oxycodone Hcl	Oxycodone Hcl	111	29
Trazodone Hcl	Trazodone Hcl	107	25
Mirtazapine	Mirtazapine	105	18
Duloxetine Hcl	Duloxetine Hcl	93	18
Insulin Lispro Kwikpen U-100	Insulin Lispro	92	16
Carvedilol	Carvedilol	91	18
Metformin Hcl	Metformin Hcl	91	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	15
Quetiapine Fumarate	Quetiapine Fumarate	80	19
Alendronate Sodium	Alendronate Sodium	73	15
Pantoprazole Sodium	Pantoprazole Sodium	68	21
Spironolactone	Spironolactone	63	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	62	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	62	suppressed
Methocarbamol	Methocarbamol	62	19
Jardiance	Empagliflozin	60	suppressed
Torsemide	Torsemide	59	20
Simvastatin	Simvastatin	54	suppressed
Allopurinol	Allopurinol	53	12
Donepezil Hcl	Donepezil Hcl	52	suppressed
Aripiprazole	Aripiprazole	48	suppressed
Levetiracetam	Levetiracetam	47	suppressed
Ondansetron Odt	Ondansetron	47	22
Prednisone	Prednisone	47	24
Rosuvastatin Calcium	Rosuvastatin Calcium	43	suppressed
Atenolol	Atenolol	40	suppressed
Famotidine	Famotidine	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	37	suppressed
Memantine Hcl	Memantine Hcl	37	suppressed
Buspirone Hcl	Buspirone Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	12
Warfarin Sodium	Warfarin Sodium	33	suppressed
Olanzapine	Olanzapine	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	15
Baclofen	Baclofen	30	suppressed
Methenamine Hippurate	Methenamine Hippurate	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Finasteride	Finasteride	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	20
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Risperidone	Risperidone	26	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	25	13
Lorazepam	Lorazepam	25	16
Chlorthalidone	Chlorthalidone	24	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Latanoprost	Latanoprost	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Ozempic	Semaglutide	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Cephalexin	Cephalexin	20	suppressed
Fluconazole	Fluconazole	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	13
Glimepiride	Glimepiride	20	suppressed
Glipizide	Glipizide	20	suppressed
Lurasidone Hcl	Lurasidone Hcl	20	suppressed
Omeprazole	Omeprazole	20	11
Primidone	Primidone	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Digoxin	Digoxin	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Methadone Hcl	Methadone Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	11
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Zonisamide	Zonisamide	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Dapagliflozin	Dapagliflozin Propanediol	12	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Matzim La	Diltiazem Hcl	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error